Anixa Biosciences, Inc.
Anixa Biosciences, Inc. (ANIX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
anix · pe ratio · data through Oct 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Anixa Biosciences, Inc. (ANIX) measures how much investors pay for each dollar of the company's trailing earnings. ANIX's current PE ratio of N/A is calculated by dividing its stock price of $2.46 by its TTM earnings per share of -$0.31.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-10-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Anixa Biosciences, Inc.You ANIX | $82M | N/A | — | -$0.31 |
 Acumen Pharmaceuticals, Inc. ABOS | $131M | N/A | — | -$2.00 |
 Actuate Therapeutics Inc ACTU | $44M | N/A | — | -$1.06 |
 Agenus Inc. AGEN | $131M | 811.87x | — | $0.00 |
 Entera Bio Ltd. ENTX | $59M | N/A | — | -$0.25 |
 TuHURA Biosciences, Inc. HURA | $130M | N/A | — | -$0.63 |
 Inovio Pharmaceuticals, Inc. INO | $58M | N/A | — | -$0.18 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-10-31Latest FY2025 | — | $-0.34 | — | |
2024-10-31 FY2024 | — | $-0.39 | — | |
2023-10-31 FY2023 | — | $-0.32 | — | |
2022-10-31 FY2022 | — | $-0.45 | — | |
2021-10-31 FY2021 | — | $-0.45 | — | |
2020-10-31 FY2020 | — | $-0.46 | — | |
2019-10-31 FY2019 | — | $-0.59 | — | |
2018-10-31 FY2018 | — | $-0.79 | — | |
2017-10-31 FY2017 | — | $-0.41 | — | |
2016-10-31 FY2016 | — | $-0.57 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Anixa Biosciences, Inc. (ANIX) measures how much investors pay for each dollar of the company's trailing earnings. ANIX's current PE ratio of N/A is calculated by dividing its stock price of $2.46 by its TTM earnings per share of -$0.31.
Frequently asked questions
ANIX pe ratio · 6 questionsANIX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.46 and TTM EPS of -$0.31. Data sourced from Financial Modeling Prep via ANIX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Anixa Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09